INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$2.6M

$2,610,044

View Combined Trades

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2026-03-02 $246,207 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2026-03-02	$246,207	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2026-03-02 $386,659 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2026-03-02	$386,659	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2026-02-02 $30,452 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2026-02-02	$30,452	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2026-02-02 $461,593 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2026-02-02	$461,593	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2025-12-01 $315,886 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2025-12-01	$315,886	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2025-12-01 $119,469 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2025-12-01	$119,469	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2025-11-03 $651,225 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2025-11-03	$651,225	S	Form 4
SYRE S Spyre Therapeutics, Inc. Turtle Cameron • CEO 10b5-1 Sell 2025-11-03 $398,553 View Form 4 →
SYRE	Spyre Therapeutics, Inc.	Turtle Cameron CEO 10b5-1 Sell	2025-11-03	$398,553	S	Form 4